Gastroesophageal Junction Cancer
📧 Sign up to get email alerts when something new happens for Gastroesophageal Junction Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-11-25Clinical Trial Update: Cetuximab, Cisplatin, and Irinotecan in Treating Patients With Metastatic Esophageal Cancer, Gastroesophageal Junction Cancer, or Gastric Cancer That Did Not Respond to Previous Irinotecan and Cisplatin [Phase 2]
This Phase 2 trial evaluated the combination of cetuximab, cisplatin, and irinotecan in patients with metastatic esophageal cancer, gastroes…
-
CLINICAL_TRIALS trial_result · 2015-11-18Clinical Trial Update: An Efficacy Study in Gastric and Gastroesophageal Junction Cancer Comparing Ipilimumab Versus Standard of Care Immediately Following First Line Chemotherapy [Phase 2]
Phase 2 efficacy study results comparing ipilimumab to the standard of care after first-line chemotherapy in locally advanced unresectable o…
-
CLINICAL_TRIALS trial_result · 2015-10-08Clinical Trial Update: Nab-Paclitaxel as Salvage Treatment in Locally Advanced or Metastatic Gastric Cancer [Phase 2]
Phase 2 trial evaluating nab-paclitaxel as salvage therapy in locally advanced or metastatic gastric cancer has completed.
-
CLINICAL_TRIALS trial_result · 2015-09-30Clinical Trial Update: Radiotherapy,Chemotherapy,Before and After Surgery in Advanced Esophageal or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial evaluating radiotherapy and chemotherapy given before and after surgery for advanced esophageal or gastroesophageal j…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Erlotinib and Avastin in Patients With Cancer of the Esophagus or Gastroesophageal Junction [Phase 2]
This is a Phase 2 trial update of the combination erlotinib and bevacizumab in patients with cancer of the esophagus or gastroesophageal jun…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-06-03Clinical Trial Update: Significance of Peritoneal Washing Cytology Before and After Neoadjuvant Chemotherapy in Patients With Esophagogastric-junction Cancer
This completed trial update evaluates the significance of peritoneal washing cytology before and after neoadjuvant chemotherapy in patients …
-
CLINICAL_TRIALS trial_result · 2015-01-13Clinical Trial Update: Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer [Phase 1]
Phase I trial of MT110 in multiple solid tumors has completed enrollment, evaluating MT110 in lung cancer (non-small cell and small cell), g…
-
CLINICAL_TRIALS trial_result · 2015-01-08Clinical Trial Update: Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating docetaxel with or without vandetanib in metastatic gastric cancer and gastroesophageal junction cancer was terminat…
-
CLINICAL_TRIALS trial_result · 2014-12-05Clinical Trial Update: Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and Radiation
This completed clinical trial updates the incidence and patterns of nausea and vomiting in patients treated with combined chemotherapy and r…
-
CLINICAL_TRIALS trial_result · 2014-12-02Clinical Trial Update: Safety and Efficacy of Neoadjuvant Radiochemotherapy in Adenocarcinoma of the Gastric-oesophageal Junction [Phase 1, Phase 2]
Phase 1/2 trial evaluating neoadjuvant radiochemotherapy for adenocarcinoma at the gastroesophageal junction has completed, focusing on safe…
-
CLINICAL_TRIALS trial_result · 2014-10-20Clinical Trial Update: Combination Chemotherapy Followed By Chemoradiotherapy, With or Without Surgery, in Treating Patients With Resectable Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 2]
Phase 2 trial evaluating sequence of combination chemotherapy followed by chemoradiotherapy with or without surgery for resectable locally a…
-
CLINICAL_TRIALS trial_result · 2014-09-12Clinical Trial Update: Assess the Efficacy of AZD8931 in Combination With Paclitaxel Versus Paclitaxel Alone in Patients With Gastric Cancer [Phase 2]
Phase 2 trial evaluating AZD8931 in combination with paclitaxel versus paclitaxel alone in metastatic gastric/gastroesophageal junction canc…
-
CLINICAL_TRIALS trial_result · 2014-07-29Clinical Trial Update: Adjuvant Chemoradiation Therapy for Gastric or Gastroesophageal Junction Adenocarcinoma [EARLY_Phase 1]
This update notes the completion of an early Phase 1 trial evaluating adjuvant chemoradiation therapy for gastric cancer and gastroesophagea…
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Gefitinib, Cisplatin, Irinotecan, and Radiation Therapy Before Surgery in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery [Phase 1]
Phase 1 trial update of gefitinib with cisplatin and irinotecan (with radiation therapy) as neoadjuvant treatment for esophageal cancer or g…
-
CLINICAL_TRIALS trial_result · 2014-02-28Clinical Trial Update: Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial update for a multimodal approach (chemotherapy, radiation, cetuximab, followed by surgery, then docetaxel and cetuximab) in es…
-
CLINICAL_TRIALS trial_result · 2013-07-18Clinical Trial Update: T900607 in Treating Patients With Gastroesophageal Junction Cancer [Phase 2]
Phase 2 clinical trial update for the agent T900607 in patients with gastric cancer and gastroesophageal junction cancer; the study status i…
-
CLINICAL_TRIALS trial_result · 2013-06-24Clinical Trial Update: Erlotinib in Treating Patients With Locally Advanced or Metastatic Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial updates on erlotinib for locally advanced or metastatic stomach cancer and gastroesophageal junction cancer.
-
CLINICAL_TRIALS trial_result · 2013-03-21Clinical Trial Update: Combination Chemotherapy and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 1]
A Phase 1 study investigated the safety and dosing of a combination chemotherapy and radiation therapy regimen for esophageal cancer and gas…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Arsenic Trioxide in Treating Patients With Advanced Cancer of the Esophagus or Gastroesophageal Junction [Phase 2]
A Phase 2 trial tested arsenic trioxide in advanced esophageal and gastroesophageal junction cancers. The study was terminated.
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer [Phase 1]
A Phase 1 clinical trial update announcing completion of a study of the monoclonal antibody ABX-EGF in patients with multiple cancers, inclu…
-
CLINICAL_TRIALS trial_result · 2013-01-04Clinical Trial Update: An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer [Phase 1, Phase 2]
An open-label Phase 1/2 study evaluating chemoradiotherapy with AT-101 in locally advanced esophageal or gastroesophageal junction cancer wa…
-
CLINICAL_TRIALS trial_result · 2012-10-18Clinical Trial Update: Fluorouracil, Oxaliplatin, and Leucovorin in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating fluorouracil, oxaliplatin, and leucovorin in patients with metastatic gastric cancer or gastroesophageal junction c…
-
CLINICAL_TRIALS trial_result · 2012-09-06Clinical Trial Update: Efficacy of Pegamotecan (PEG-Camptothecin) in Localized or Metastatic Cancer of the Stomach or Gastroesophageal Junction [Phase 2]
A Phase 2 trial of pegamotecan for gastric and gastroesophageal junction cancers was terminated; the update does not include reported effica…
-
CLINICAL_TRIALS trial_result · 2012-05-01Clinical Trial Update: S0415 Cetuximab in Treating Patients With Metastatic Esophageal Cancer or Gastroesophageal Junction Cancer [Phase 2]
Phase 2 trial evaluating cetuximab in metastatic esophageal cancer or gastroesophageal junction cancer has completed with results posted in …
-
CLINICAL_TRIALS trial_result · 2012-04-03Clinical Trial Update: S0356 Oxaliplatin, 5-FU, Radiation Therapy (RT), Surgery for Pts With Stage II or III Cancer of Esophagus or Gastroesophageal (GE) Junction [Phase 2]
A Phase 2 SWOG trial evaluating a multimodal regimen of oxaliplatin, 5-fluorouracil, radiation therapy, and surgery for stage II-III esophag…